NewsRamp Science, Exploration and Discovery Podcast

Alicia Kali has founded a nonprofit institute focusing on merging biological intelligence, regenerative health, and artificial cognition to enhance human health and AI capabilities. The research areas include neurobiological and bioquantum intelligence, surpassing AGI constraints in AI development, and advancements in regenerative medicine. Alicia Kali, a renowned scientist in Orthomolecular Medic...

This podcast episode covers a range of topics including strategic investments in critical minerals projects, advancements in biotech with companies like Oncotelic Therapeutics and Creative Biolabs, significant funding in AI projects by Alphabet, developments in cancer treatment research by UCLA Health and CNS Pharmaceuticals, updates in the gold and silver mining sector, and innovative solutions i...

GeoVax Labs, Inc. reports positive interim results for its COVID-19 vaccine, Dr. Berenika Maciejewicz presents groundbreaking research on consciousness, and Kairos Pharma Ltd. will discuss interim efficacy results for ENV105 in advanced prostate cancer during a key opinion leader event. Exciting developments in healthcare and scientific advancements are shaping the future of medicine.

Sigyn Therapeutics, Inc. appoints Dr. Christoph Zaba to its Scientific Advisory Board, focusing on reducing cardiovascular disease risks through Sigyn Therapy™. Meanwhile, FORTA opens the Grand Rapids Testing Lab, dedicated to testing asphalt and concrete fibers to enhance infrastructure durability and innovation.

Aston Bay Holdings Ltd. announced promising findings from the MMT geophysical survey conducted at the Storm Copper Project on Somerset Island, Nunavut. The survey identified large conductive anomalies indicating potential high-grade zones at the Cyclone Deposit, hinting at copper sulphide mineralization. CEO Thomas Ullrich highlighted progress in permitting, economic studies, and feasibility work...

VolitionRx Ltd. partners with Werfen to assess antiphospholipid syndrome, Soligenix Inc. showcases rare disease and public health pipeline, Trilogy Metals Inc. discusses mineral projects with South32, and G Mining Ventures Corp. announces high-grade discoveries at Oko West and progress at Gurupi.

Easy Environmental Solutions Inc. receives a deposit to deploy a microbial fertilizer system in Africa, Golden Cariboo Resources Ltd. confirms a new mineralized zone at the Quesnelle Gold Quartz Mine property, Renaissance BioScience Corp. secures funding for RNA interference technology to protect canola crops, and GeoVax Labs, Inc. will present data on a COVID-19 vaccine. Additionally, DCS Rescue...

Research presented at the American Heart Association's Hypertension Scientific Sessions 2025 highlights the effectiveness of AI voice agents in improving blood pressure monitoring for older adults, leading to better patient outcomes. Additionally, a study reveals that children with higher blood pressure at age 7 have an increased risk of early cardiovascular death, emphasizing the importance of mo...

The FigHTN Phase 2 clinical trial revealed that baxdrostat, an aldosterone production inhibitor, reduced systolic blood pressure by 5% and decreased urine albumin loss by 55% in individuals with chronic kidney disease and uncontrolled hypertension. These findings suggest baxdrostat's potential to delay kidney disease progression and improve long-term health outcomes, offering a promising solution...

Registration and paper submissions are open for the 2025 World Young Scientist Summit (WYSS) in Wenzhou, China. The summit, themed 'Embracing Change: Young Scientists Shaping the Future Together,' will focus on the UN 2030 Sustainable Development Goals and feature sessions on youth development, sustainable development, technological innovation, and international collaboration. WYSS aims to empower...

Trilogy Metals Inc. is progressing high-grade mineral projects in Alaska, positioning itself as a key developer in North America's critical minerals sector. LaFleur Minerals Inc. is focusing on gold exploration in Québec, with a significant potential in the Abitibi Greenstone Belt, amidst record-high gold prices.

Recent studies presented at the American Heart Association’s Hypertension Scientific Sessions 2025 highlight the underutilization of salt substitutes in managing high blood pressure and the concerning rise in death rates from hypertensive kidney disease, particularly among certain demographic groups. Additionally, advancements in the field of biopharmaceuticals show promise in developing treatment...

Renaissance BioScience Corp. has obtained an Australian patent for their yeast-based platform technology, enabling cost-effective RNA production and delivery. This innovative technology is focused on RNAi-based biopesticides, offering precise pest control methods with enhanced environmental safety. Beyond agriculture, the technology also shows promise in animal health and human medicine, addressin...

Foremost Clean Energy Ltd. is issuing common shares to Denison Mines Corp., increasing Denison's ownership stake. Meanwhile, Kairos Pharma Ltd. will be presenting Phase 1 data on ENV105 at the World Lung Cancer Conference, focusing on its combination therapy with osimertinib to overcome drug resistance in cancer treatments.

InFlectis BioScience and Aix Marseille Université show promise in treating axonal forms of Charcot-Marie-Tooth Disease with IFB-088, seeking partnerships for clinical trials. Norsemont Mining Inc. secures funds for drilling at the Choquelimpie project, aiming to unlock its potential. Sigyn Therapeutics, Inc. plans a clinical study for Sigyn Therapy™ in high-risk cardiovascular disease subjects. Gi...

Foremost Clean Energy launches a drill program in Saskatchewan, Soligenix Inc. presents at an investment conference, Lahontan Gold Corp. reports positive drilling results in Nevada, and a study links head injuries to brain cancer risk, while McEwen Inc. announces high-grade drilling results at the Grey Fox Project.

IntegrateRNA offers Aminoacyl-tRNA In Vitro Synthesis Service for customizable tRNAs crucial in protein synthesis, while CD BioGlyco introduces Custom Glycoconjugate Synthesis for connecting glycans to proteins, lipids, or other molecules to study cell interactions and immune responses.

Alfa Chemistry now offers advanced diamond materials catering to industries like semiconductor production and biomedical research, providing precise control over abrasive removal rates and surface finish. Meanwhile, Creative Biolabs is driving the future of biopharmaceuticals through customized glycoprotein engineering services and in-depth carbohydrate analysis techniques, transforming molecular...

Zevra Therapeutics presents new data on MIPLYFFA targeting Niemann-Pick disease type C at a congress, while Clene Inc. focuses on neurodegenerative diseases with lead candidate CNM-Au8® for ALS, gearing up for a Phase 3 trial and having a late-stage MS program. Both companies offer innovative approaches to treating rare diseases with significant investment potential.

The use of PREVENT™ equations recommended in the AHA/ACC High Blood Pressure Guideline offers a more accurate risk assessment for cardiovascular disease in adults with hypertension, allowing for personalized treatment plans. Additionally, New Pacific Metals Corp. is exploring Bolivia's silver potential, while a study reveals a link between IBD and blood clot development, offering hope for improved...

MyBioSource has introduced a Sheep anti-Rat Calretinin Polyclonal antibody to their collection, targeting the vital calretinin protein involved in neurobiology and cellular calcium signaling. This antibody, with 100% sequence homology, has potential cross-reactivity with mouse, human, and non-human primate calretinin, making it valuable for researchers in neurodegeneration, calcium signaling, and...

New Pacific Metals Corp. advances its Silver Sand project in Bolivia, Foremost Clean Energy Ltd. reveals positive radon survey results in Saskatchewan, ESGold Corp. transforms abandoned mine waste into profitable operations, and a joint research team uncovers a mechanism behind resistance to cancer immunotherapy related to nerve damage.

Emperor Metals Inc. disclosed a Mineral Resource Estimate for the Duquesne West Gold Project, while 7-HOPE Alliance defended the legality and safety of 7-OH. Lahontan Gold Corp. progresses with the Santa Fe Mine Project in Nevada, Soligenix Inc. reports advancements in rare disease treatments, and McEwen Inc. shares promising gold results from Goliath Resources Limited in British Columbia.

LaFleur Minerals has significantly expanded its Swanson Project by staking 32 additional mineral claims, extending the project's strike length to over 33 kilometers. CEO Paul Ténière emphasized the integration of historical data and new surveys to define drilling targets, with plans for a fully funded drilling program to enhance discovery potential in the Abitibi region.

The Boone Heart Institute is hosting the Summit Conference 2025 focusing on preventive cardiology, while Triadic Collaboration introduces the Emotional Brain Shunting (EBS) project to study emotional and cognitive resilience under stress, proposing the 4th R for emotional re-education.